AI digital pathology (DP) significantly improves inter-pathologist agreement in fibrosis staging, particularly early-stage fibrosis (F0-F2) in MASH.
Utilization of second harmonic generation/two photon excitation fluorescence (SHG/TPEF) imaging combined with AI quantitative fibrosis (qFibrosis) enhances visualization and objective assessment of fibrosis severity.
AI assistance increases concordance for clinical trial inclusion/exclusion criteria and evaluation of fibrosis response, potentially reducing adjudication needs and increasing trial power.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
